Trial Profile
Comparison of a Single Dose Fibrinogen With Placebo and the Number of Blood Transfusions After Ascending Aorta Surgery (FIBTEG Study)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Acronyms FIBTEG
- 08 May 2019 Status changed from recruiting to discontinued.
- 04 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 04 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.